The pharmacological treatment of premature ejaculation

BJU International

Volumn 102, Issue 6, 2008, Pages 668-675

  Giuliano, François ^a   Hellstrom, Wayne J G ^b  

^a RAYMOND POINCARÉ HOSPITAL   (France)

^b TULANE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

5 HT; Premature ejaculation; Selective serotonin reuptake inhibitor; Sexual dysfunction

Indexed keywords

5 CYANO 3 [2 (DIMETHYLAMINOMETHYL)CYCLOPROPYL]INDOLE; ANESTHETIC AGENT; CITALOPRAM; CLOMIPRAMINE; DAPOXETINE; EMLA; FLUOXETINE; PAROXETINE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SEVERANCE SECRET; SILDENAFIL; TOPICAL AGENT; TRAMADOL; UNCLASSIFIED DRUG;

BEHAVIOR THERAPY; BODY WEIGHT; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; DESENSITIZATION; DIARRHEA; DISEASE ASSOCIATION; DIZZINESS; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; DRUG WITHDRAWAL; EJACULATION; ERECTILE DYSFUNCTION; HEADACHE; HUMAN; INSOMNIA; MENTAL DISEASE; MONOTHERAPY; NAUSEA; NEUROLOGIC DISEASE; NEUROPHYSIOLOGY; PAIN; PARESTHESIA; PREMATURE EJACULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTONIN SYNDROME; SEXUAL DYSFUNCTION; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; SHORT SURVEY; SIDE EFFECT; SKIN DISEASE; SOMNOLENCE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, TOPICAL; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; DRUG THERAPY, COMBINATION; EJACULATION; HUMANS; MALE; META-ANALYSIS AS TOPIC; PHOSPHODIESTERASE INHIBITORS; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TREATMENT OUTCOME;

EID: 50049129061     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07719.x     Document Type: Short Survey

References (91)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999 281 : 537 44
2. Rosen RC. Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep 2000 2 : 189 95
3. Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J. The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol 2007 51 : 816 24
4. Patrick DL, Althof SE, Pryor JL et al. Premature ejaculation: an observational study of men and their partners. J Sex Med 2005 2 : 358 67
5. Giuliano F, Patrick DL, Porst H et al. Premature ejaculation: results from a five-country european observational study. Eur Urol 2008 53 : 1048 57
6. Rowland DL, Patrick DL, Rothman M, Gagnon DD. The psychological burden of premature ejaculation. J Urol 2007 177 : 1065 70
7. Pryor JL, Althof SE, Steidle C et al. Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation: integrated analysis of two randomized, double-blind, placebo-controlled trials. Lancet 2006 368 : 929 37
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Text Revision. Washington, DC : American Psychiatric Association, 2000
9. National Center for Health Statistics. International Classification of Diseases, Ninth Revision, Clinical Modifications (ICD-9-CM). 2008. Available at: http://www.cdc.gov/nchs/about/otheract/icd9/abticd9.htm Accessed 8 January 2008
10. Lue TF, Giuliano F, Montorsi F et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med 2004 1 : 6 23
11. Montague DK, Jarow J, Broderick G et al. AUA guideline on the pharmacologic management of premature ejaculation. J Urol 2004 172 : 290 4
12. Rosen RC, McMahon CG, Niederberger C, Broderick GA, Jamieson C, Gagnon DD. Correlates to the clinical diagnosis of premature ejaculation: results from a large observational study of men and their partners. J Urol 2007 177 : 1059 64
13. Cooper AJ, Cernovsky ZZ, Colussi K. Some clinical and psychometric characteristics of primary and secondary premature ejaculators. J Sex Marital Ther 1993 19 : 276 88
14. Waldinger MD. Premature ejaculation: definition and drug treatment. Drugs 2007 67 : 547 68
15. Piediferro G, Colpi EM, Castiglioni F, Nerva F. Premature ejaculation. 1. Definition and etiology. Arch Ital Urol Androl 2004 76 : 181 7
16. Rowland DL. Psychophysiology of ejaculatory function and dysfunction. World J Urol 2005 23 : 82 8
17. Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005 294 : 2996 3002
18. Shamloul R. Chronic prostatitis in premature ejaculation: a cohort study in 153 men. J Sex Med 2006 3 : 150 4
19. Waldinger MD, Rietschel M, Nothen MM, Hengeveld MW, Olivier B. Familial occurrence of primary premature ejaculation. Psychiatr Genet 1998 8 : 37 40
20. Waldinger MD. The neurobiological approach to premature ejaculation. J Urol 2002 168 : 2359 67
21. Coolen LM, Allard J, Truitt WA, McKenna KE. Central regulation of ejaculation. Physiol Behav 2004 83 : 203 15
22. Giuliano F, Clement P. Serotonin and premature ejaculation: from physiology to patient management. Eur Urol 2006 50 : 454 66
23. Hamson DK, Watson NV. Regional brainstem expression of Fos associated with sexual behavior in male rats. Brain Res 2004 1006 : 233 40
24. Heeb MM, Yahr P. Anatomical and functional connections among cell groups in the gerbil brain that are activated with ejaculation. J Comp Neurol 2001 439 : 248 58
25. Meisel RL, Sachs BD. The physiology of male sexual behavior. In Knobil E, Neill JD, The Physiology of Reproduction, 2nd edn. New York : Raven Press, 1994 : 3 105
26. Marson L, McKenna KE. The identification of a brainstem site controlling spinal sexual reflexes in male rats. Brain Res 1990 515 : 303 8
27. Murphy AZ, Hoffman GE. Distribution of gonadal steroid receptor-containing neurons in the preoptic-periaqueductal gray-brainstem pathway: a potential circuit for the initiation of male sexual behavior. J Comp Neurol 2001 438 : 191 212
28. Marson L. Lesions of the periaqueductal gray block the medial preoptic area-induced activation of the urethrogenital reflex in male rats. Neurosci Lett 2004 367 : 278 82
29. Olivier B, van Oorschot R, Waldinger MD. Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour. Int Clin Psychopharmacol 1998 13 (Suppl. 6 S9 14
30. Hillegaart V, Ahlenius S. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181. Br J Pharmacol 1998 125 : 1733 43
31. Hull EM, Du J, Lorrain DS, Matuszewich L. Extracellular dopamine in the medial preoptic area: implications for sexual motivation and hormonal control of copulation. J Neurosci 1995 15 : 7465 71
32. Filippi S, Vignozzi L, Vannelli GB, Ledda F, Forti G, Maggi M. Role of oxytocin in the ejaculatory process. J Endocrinol Invest 2003 26 : 82 6
33. Bitran D, Hull EM. Pharmacological analysis of male rat sexual behavior. Neurosci Biobehav Rev 1987 11 : 365 89
34. Giuliano F, Clement P. Physiology of ejaculation: emphasis on serotonergic control. Eur Urol 2005 48 : 408 17
35. Waldinger MD, Berendsen HH, Blok BF, Olivier B, Holstege G. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res 1998 92 : 111 8
36. Ahlenius S, Larsson K. Specific involvement of central 5-HT1A receptors in the mediation of male rat ejaculatory behavior. Neurochem Res 1997 22 : 1065 70
37. Waldinger MD, Olivier B. Utility of selective serotonin reuptake inhibitors in premature ejaculation. Curr Opin Invest Drugs 2004 5 : 743 7
38. Waldinger MD. Lifelong premature ejaculation: from authority-based to evidence-based medicine. BJU Int 2004 93 : 201 7
39. Waldinger MD. Relevance of an evidence-based ejaculation time cutoff point for neurobiological research of premature ejaculation. J Comp Neurol 2005 493 : 46 50
40. Giuliano F, Patrick DL, Porst H et al. Premature ejaculation: results from a European observational study. Poster presented at the 2006 Annual Meeting of the European Association for Urology; April 5-8, 2006 Paris, France 2007
41. Rowland D, Perelman M, Althof S et al. Self-reported premature ejaculation and aspects of sexual functioning and satisfaction. J Sex Med 2004 1 : 225 32
42. Patrick DL, Rothman M, McNulty P, Jamieson C, Ho KF. Can single items adequately capture outcomes of premature ejaculation (PE)? J Urol 2005 173 (Suppl. 338
43. Gur E, Lerer B, Newman ME. Chronic clomipramine and triiodothyronine increase serotonin levels in rat frontal cortex in vivo: relationship to serotonin autoreceptor activity. J Pharmacol Exp Ther 1999 288 : 81 7
44. Kim SC, Seo KK. Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study. J Urol 1998 159 : 425 7
45. Segraves RT, Saran A, Segraves K, Maguire E. Clomipramine versus placebo in the treatment of premature ejaculation: a pilot study. J Sex Marital Ther 1993 19 : 198 200
46. Strassberg DS, de Gouveia Brazao CA, Rowland DL, Tan P, Slob AK. Clomipramine in the treatment of rapid (premature) ejaculation. J Sex Marital Ther 1999 25 : 89 101
47. Waldinger MD, Zwinderman AH, Olivier B. On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment. Eur Urol 2004 46 : 510 6
48. Haensel SM, Rowland DL, Kallan KT, Koos Slob A. Clomipramine and sexual function in men with premature ejaculation and controls. J Urol 1996 156 : 1310 5
49. Abdel-Hamid IA, El Naggar EA, El Gilany AH. Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res 2001 13 : 41 5
50. Rowland DL, Tai WL, Brummett K, Slob AK. Predicting responsiveness to the treatment of rapid ejaculation with 25 mg clomipramine as needed. Int J Impot Res 2004 16 : 354 7
51. Althof SE, Levine SB, Corty EW, Risen CB, Stern EB, Kurit DM. A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples. J Clin Psychiatry 1995 56 : 402 7
52. Rosen RC. Alcohol and drug effects on sexual responses: human experimental and clinical studies. Annu Rev Sex Res 1991 2 : 119 79
53. Segraves RT. Treatment-emergent sexual dysfunction in affective disorder: a review and management strategies. J Clin Psychiatry Monogr 1993 11 : 57 60
54. Kim SW, Paick JS. Short-term analysis of the effects of as needed use of sertraline at 5 PM for the treatment of premature ejaculation. Urology 1999 54 : 544 7
55. Waldinger MD, Zwindermann AH, Schweitzer DH, Olivier B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res 2004 16 : 369 81
56. Wang WF, Chang L, Minhas S, Ralph DJ. Selective serotonin reuptake inhibitors in the treatment of premature ejaculation. Chin Med J (Engl) 2007 120 : 1000 6
57. Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 1999 19 : 67 85
58. Goldstein BJ, Goodnick PJ. Selective serotonin reuptake inhibitors in the treatment of affective disorders - III. Tolerability, safety and pharmacoeconomics. J Psychopharmacol 1998 12 : S55 S87
59. Black K, Shea C, Dursun S, Kutcher S. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci 2000 25 : 255 61
60. Haddad P. The SSRI discontinuation syndrome. J Psychopharmacol 1998 12 : 305 13
61. Tamam L, Ozpoyraz N. Selective serotonin reuptake inhibitor discontinuation syndrome: a review. Adv Ther 2002 19 : 17 26
62. Nelson EB, Keck PE Jr, McElroy SL. Resolution of fluoxetine-induced sexual dysfunction with the 5-HT3 antagonist granisetron. J Clin Psychiatry 1997 58 : 496 7
63. Lane R, Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol 1997 17 : 208 21
64. Balon R. Antidepressants in the treatment of premature ejaculation. J Sex Marital Ther 1996 22 : 85 96
65. McMahon CG. Treatment of premature ejaculation with sertraline hydrochloride: a single-blind placebo controlled crossover study. J Urol 1998 159 : 1935 8
66. McMahon CG, Touma K. Treatment of premature ejaculation with paroxetine hydrochloride. Int J Impot Res 1999 11 : 241 5
67. El MM, Blier P. Responsiveness of 5-HT (1A) and 5-HT2 receptors in the rat orbitofrontal cortex after long-term serotonin reuptake inhibition. J Psychiatry Neurosci 2005 30 : 268 74
68. Sharlip I. Diagnosis and treatment of premature ejaculation: the physician's perspective. J Sex Med 2005 2 (Suppl. 2 103 9
69. Andersson KE, Mulhall JP, Wyllie MG. Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for on-demand treatment of premature ejaculation. BJU Int 2006 97 : 311 5
70. Modi NB, Dresser MJ, Simon M, Lin D, Desai D, Gupta S. Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation. J Clin Pharmacol 2006 46 : 301 9
71. Shabsigh R, Broderick G, Miloslavsky M, Bull S, Nilsson-Neijber A. Long-term safety and tolerability of dapoxetine for the treatment of men with premature ejaculation. Submitted to the 21st Annual Congress of the European Association of Urology, Paris, France April 5-8, 2006
72. Salonia A, Maga T, Colombo R et al. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol 2002 168 : 2486 9
73. Abdel-Hamid IA. Phosphodiesterase 5 inhibitors in rapid ejaculation: potential use and possible mechanisms of action. Drugs 2004 64 : 13 26
74. Chen J, Mabjeesh NJ, Matzkin H, Greenstein A. Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation. Urology 2003 61 : 197 200
75. Ekmekcioglu O, Inci M, Demirci D, Tatlisen A. Effects of sildenafil citrate on ejaculation latency, detumescence time, and refractory period: placebo-controlled, double-blind, crossover laboratory setting study. Urology 2005 65 : 347 52
76. Mondaini N, Ponchietti R, Muir GH et al. Sildenafil does not improve sexual function in men without erectile dysfunction but does reduce the postorgasmic refractory time. Int J Impot Res 2003 15 : 225 8
77. Chia S. Management of premature ejaculation - a comparison of treatment outcome in patients with and without erectile dysfunction. Int J Androl 2002 25 : 301 5
78. McMahon CG, Stuckey BG, Andersen M et al. Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation. J Sex Med 2005 2 : 368 75
79. McMahon CG, McMahon CN, Leow LJ, Winestock CG. Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: a systematic review. BJU Int 2006 98 : 259 72
80. Safarinejad MR, Hosseini SY. Safety and efficacy of tramadol in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. J Clin Psychopharmacol 2006 26 : 27 31
81. Salem EA, Wilson SK, Bissada NK, Delk JR, Hellstrom WJ, Cleves MA. Tramadol HCL has promise in on-demand use to treat premature ejaculation. J Sex Med 2008 5 : 188 93
82. Eradiri O, Sista S, Lai JC-K, Danyluk A, Brett V. Bioavailability of extended-release and immediate-release formulations of tramadol HCl. J Clin Pharmacol 2006 46 : 1091
83. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006 174 : 1589 94
84. Busato W, Galindo CC. Topical anaesthetic use for treating premature ejaculation: a double-blind, randomized, placebo-controlled study. BJU Int 2004 93 : 1018 21
85. Wyllie MG, Henry R, Morales A. Practical and effective treatment of premature ejaculation (PE) with a lidocaine-prilocaine spray. Proceedings of the AUA 98th Annual Meeting, 2003
86. Dinsmore WW, Hackett G, Goldmeier D et al. Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol-delivery form of lidocaine-prilocaine for treating premature ejaculation. BJU Int 2006 99 : 369 75
87. Atikeler MK, Gecit I, Senol FA. Optimum usage of prilocaine-lidocaine cream in premature ejaculation. Andrologia 2002 34 : 356 9
88. Atan A, Basar MM, Tuncel A, Ferhat M, Agras K, Tekdogan U. Comparison of efficacy of sildenafil-only, sildenafil plus topical EMLA cream, and topical EMLA-cream-only in treatment of premature ejaculation. Urology 2006 67 : 388 91
89. Henry R, Morales A. Topical lidocaine-prilocaine spray for the treatment of premature ejaculation: a proof of concept study. Int J Impot Res 2003 15 : 277 81
90. Choi HK, Jung GW, Moon KH et al. Clinical study of SS-cream in patients with lifelong premature ejaculation. Urology 2000 55 : 257 61
91. Choi HK, Xin ZC, Choi YD, Lee WH, Mah SY, Kim DK. Safety and efficacy study with various doses of SS-cream in patients with premature ejaculation in a double-blind, randomized, placebo controlled clinical study. Int J Impot Res 1999 11 : 261 4